Clermont-Ferrand, 21 September 2020 – (FR0004177046 METEX), METabolic EXplorer (METEX), today announced, as part of the strategic partnership between its subsidiary METEX NØØVISTA and Royal DSM, the commercial launch of TILAMAR® PDO with NØØVISTATM for the cosmetics market.
Considering the upcoming start-up of the production unit of PDO (1.3 Propanediol) and BA (Butyric acid) at Carling St-Avold in Moselle, expected in the second quarter of 2021, DSM, one of the industry’s leading suppliers of ingredients and innovative solutions to the personal care, home care and fine fragrance markets, has started promoting to its international customers the only bio-based non-GMO PDO made in Europe from a technology developed by METEX.
Based on its application development expertise and innovation capabilities, DSM presented the benefits of TILAMAR® PDO with NØØVISTATM in various cosmetic applications during a launch webinar. DSM notably demonstrated that TILAMAR® PDO with NØØVISTATM respects the balance of the skin microbiome and it has been recognized and labelled “Microbiome-friendly” by an independation certification body. This webinar can be seen or reviewed by registering from the following link : TILAMAR® PDO with NØØVISTA™ webinar and the promotional video can be seen on DSM website : TILAMAR® PDO with NØØVISTA™ promotional video .
A thousand samples of TILAMAR® PDO with NØØVISTATM from several batches produced in the METabolic EXplorer demonstrator, have been prepared and made available for DSM customers around the world wishing to test the product and validate its performance in formulating or in development of new products.
This commercial campaign also highlights the societal impact of the production unit operated by METEX NØØVISTA. This plant, located on the Carling-St Avold CHEMESIS platform in Moselle, will produce the TILAMAR® PDO with NØØVISTATM from renewable raw materials coming from local agribusiness and it will employ 50 people in the heart of a territory under industrial conversion. This unit demonstrates that METEX’s technologies, which reconcile industry and ecology, two pillars of the €100 billion recovery plan announced by the French Prime Minister, effectively address the major current challenges we face.
Benjamin Gonzalez, CEO of METabolic EXplorer, said : “The commercial launch of TILAMAR® PDO with NØØVISTATM by DSM embodies our partner’s voluntary commitment to position, in the cosmetics market, a value proposition integrating sustainability that meet the expectations of consumers in terms of societal and environmental impact ; expectations which are clearly emphasized by the health crisis we are experiencing.”
About METabolic EXplorer – www.metabolic-explorer.com
Using renewable raw materials, the company develops and industrialises innovative and competitive industrial fermentation processes as alternative to petrochemical processes to meet consumers’ new societal expectations and the objectives of the energy transition. Its functional ingredients of natural origin are used in the formulation of cosmetic products, nutrition-animal health or as intermediates for the synthesis of biomaterials.
The construction of its first production unit, through its subsidiary METEX NØØVISTA, will bring 1.3 propanediol (PDO) and butyric acid (BA) on the market.
Based at the Clermont Limagne technology park, near Clermont-Ferrand, METabolic EXplorer is listed on Euronext in Paris (Compartment C, METEX) and is included in the CAC Small Index.
About DSM – Bright Science. Brighter Living.™
Royal DSM is a global, purpose-led, science-based company active in Nutrition, Health and Sustainable Living. DSM’s purpose is to create brighter lives for all. DSM addresses with its products and solutions some of the world’s biggest challenges while simultaneously creating economic, environmental and societal value for all its stakeholders – customers, employees, shareholders, and society at large. DSM delivers innovative solutions for human nutrition, animal nutrition, personal care and aroma, medical devices, green products and applications, and new mobility and connectivity. DSM and its associated companies deliver annual net sales of about €10 billion with approximately 23,000 employees. The company was founded in 1902 and is listed on Euronext Amsterdam.
Get free financial information on METabolic EXplorer by registering with:
Investor relations – ACTIFIN –
Tél : + 33 (0) 1 56 88 11 11
mail : email@example.com
Media relations – ACTIFIN –
Tél : + 33 (0) 1 56 88 11 11
mail : firstname.lastname@example.org